|
Volumn 51, Issue 8, 2007, Pages 3038-3039
|
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-β-lactamase VIM-12 [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
AMOXICILLIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
AZTREONAM;
CEFEPIME;
CEFOTAXIME;
CEFOXITIN;
CEFTAZIDIME;
CIPROFLOXACIN;
COTRIMOXAZOLE;
ERTAPENEM;
GENTAMICIN;
IMIPENEM;
MEROPENEM;
METALLO BETA LACTAMASE;
PIPERACILLIN PLUS TAZOBACTAM;
PROTEIN VIM 1;
PROTEIN VIM 12;
PROTEIN VIM 2;
TETRACYCLINE;
UNCLASSIFIED DRUG;
BACTERIAL GENE;
BACTERIUM ISOLATE;
BLA VIM 12 GENE;
DIAGNOSTIC KIT;
ESCHERICHIA COLI;
KLEBSIELLA PNEUMONIAE;
LETTER;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RESTRICTION FRAGMENT LENGTH POLYMORPHISM;
AGED, 80 AND OVER;
ANTI-BACTERIAL AGENTS;
BETA-LACTAMASES;
CONJUGATION, GENETIC;
ESCHERICHIA COLI;
ESCHERICHIA COLI INFECTIONS;
HUMANS;
MALE;
MICROBIAL SENSITIVITY TESTS;
PLASMIDS;
RECOMBINATION, GENETIC;
|
EID: 34547621455
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.00374-07 Document Type: Letter |
Times cited : (8)
|
References (8)
|